TropoFour Therapeutics Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
TropoFour Therapeutics General Information
Description
Developer of small molecule therapeutics intended for the treatment of blood platelet-related disorders. The company's technology modulates the activity of Tropomyosin four to regulate blood platelet production, enabling healthcare providers to treat conditions such as essential thrombocythaemia and cardiovascular disease.
Contact Information
Corporate Office
- 106 Ashley Road
- Newmarket CB8 8DB
- England, United Kingdom
Corporate Office
- 106 Ashley Road
- Newmarket CB8 8DB
- England, United Kingdom
TropoFour Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 10-Nov-2020 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | 25-Nov-2019 | Completed | Startup |
TropoFour Therapeutics FAQs
-
When was TropoFour Therapeutics founded?
TropoFour Therapeutics was founded in 2019.
-
Where is TropoFour Therapeutics headquartered?
TropoFour Therapeutics is headquartered in Newmarket, United Kingdom.
-
What industry is TropoFour Therapeutics in?
TropoFour Therapeutics’s primary industry is Drug Discovery.
-
Is TropoFour Therapeutics a private or public company?
TropoFour Therapeutics is a Private company.
-
What is TropoFour Therapeutics’s current revenue?
The current revenue for TropoFour Therapeutics is .
-
How much funding has TropoFour Therapeutics raised over time?
TropoFour Therapeutics has raised $12.9K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process